Now, research shows a person’s drink of choice may say something about their lifestyle. Simply put, beer drinkers might be lagging when it comes to diet, exercise and smoking. Lead study author ...
GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.
When Camryn Clements’ husband, an internal medicine doctor in training at the time, faced a series of health issues, the ...
The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...
The sudden change caused him significant stress, leading to a period where he refused to eat for several days,” the New ...
We spoke to a a primary care physician for tips on how to prioritize our health as we age — from our 30s through our 70s and ...
Dr. Samir Softic, M.D. is medical director of the Pediatric Fatty Liver Clinic. Dr. Aurelia Radulescu, M.D., medical director ...
In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...
The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...
In 2023, global liver disease medical societies and patient groups formalized the decision to rename non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver ...
Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.
2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback